You can buy or sell COLL and other stocks, options, ETFs, and crypto commission-free!
Collegium Pharmaceutical, Inc. operates as a pharmaceutical company, which engages in the developing and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR. Read More The Xtampza ER provides pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. The Nucynta ER for the treatment of chronic pain and neuropathic pain associated with diabetic peripheral neuropathy. The Nucynta is a release formulation of tapentadol indicated for the management of acute pain severe enough to require an opioid analgesic. The company was founded by Michael Thomas Heffernan in October 2003 and is headquartered in Stoughton, MA.
52 Week High
52 Week Low
Yahoo FinanceMay 11
Edited Transcript of COLL earnings conference call or presentation 8-May-19 8:30pm GMT
Q1 2019 Collegium Pharmaceutical Inc Earnings Call Canton May 11, 2019 (Thomson StreetEvents) -- Edited Transcript of Collegium Pharmaceutical Inc earnings conference call or presentation Wednesday, May 8, 2019 at 8:30:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Alex Dasalla Collegium Pharmaceutical, Inc. - Head of IR * Jos...
Yahoo FinanceMay 9
Were Hedge Funds Right About Dumping Collegium Pharmaceutical Inc ?
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period.
Expected Aug 7, After Hours